EUVIMEDEUVIMED entdecken
Crossref

Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors

Dinar Adriaty, Hery Suwito, Ni Nyoman Tri Puspaningsih

Pharmacognosy Journal · 01.07.2026 · 18 (2) · 171-180

DOI: 10.5530/pj.2026.18.131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Journal, online erschienen am 01.07.2026. Verfasst von Dinar Adriaty und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Adriaty, D., Suwito, H., & Puspaningsih, N. N. T. (2026). Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors. Pharmacognosy Journal, 18(2), 171-180. https://doi.org/10.5530/pj.2026.18.131

Vancouver

Adriaty D, Suwito H, Puspaningsih NNT. Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors. Pharmacognosy Journal. 2026;18(2):171-180. doi:10.5530/pj.2026.18.131

BibTeX
@article{Adriaty2026,
  author = {Adriaty, Dinar and Suwito, Hery and Puspaningsih, Ni Nyoman Tri},
  title = {Design and Virtual Screening of Dihydropyrimidinone and Chromene-Based Derivatives as Potential SARS-CoV-2 NSP16 Methyltransferase Inhibitors},
  journal = {Pharmacognosy Journal},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {171--180},
  doi = {10.5530/pj.2026.18.131}
}
Kostenlos starten →